Skip to main content

Table 7 Treatment indications for bone sparing medication in the SALT Osteoporosis Study

From: Design of the SALT Osteoporosis Study: a randomised pragmatic trial, to study a primary care screening and treatment program for the prevention of fractures in women aged 65 years or older

Treatment indications
Lumbar fracture on IVA with a vertebral height reduction ≥20%a
Thoracic fracture on IVA with a vertebral height reduction ≥25%a
Fracture risk according to FRAX ≥age specific threshold (see Table 6) and
DXA (hip and/or spine) T-score ≤ −2
Treatment indication according to the actual Dutch guideline for GP’s for primary osteoporosis (see Table 1)
  1. DXA dual-energy x-ray absorptiometry, FRAX fracture risk assessment tool, GP general practitioners, IVA instant vertebral assessment
  2. aAccording to the semi-quantitative technique of Genant [30]